Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#121 / 200 Total
HBNB - Hotel101 Global Holdings Corp - Stock Price Chart
TickerHBNB [NASD]
CompanyHotel101 Global Holdings Corp
CountryHong Kong
IndustryTravel Services
Market Cap21.25MEPS (ttm)0.27
P/E12.51EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.43EPS Q/Q25.99%
Dividend-Sales Q/Q-
Insider Own27.25%Inst Own82.96%
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume166.66K52W Range2.75 - 19.28
Jun-27-25 08:05PM HOTEL101 GLOBAL RECEIVES APPROVAL TO LIST ON NASDAQ UNDER "HBNB" (PR Newswire) +13.35% -65.98%
JVSPAC Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on April 20, 2021 and is headquartered in Hong Kong.
SGML - Sigma Lithium Corporation - Stock Price Chart
TickerSGML [NASD]
CompanySigma Lithium Corporation
CountryBrazil
IndustryOther Industrial Metals & Mining
Market Cap577.54MEPS (ttm)-0.36
P/E-EPS this Y98.34%
Forward P/E16.40EPS next Y4457.20%
PEG-EPS past 5Y-52.40%
P/S3.11EPS next 5Y-
P/B5.44EPS Q/Q167.78%
Dividend-Sales Q/Q27.54%
Insider Own45.98%Inst Own35.10%
Insider Trans0.00%Inst Trans-0.22%
Short Float18.13%EarningsMay 15/b
Analyst Recom1.00Target Price12.61
Avg Volume1.46M52W Range4.25 - 15.56
Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.
BSGM - Biosig Technologies Inc - Stock Price Chart
TickerBSGM [NASD]
CompanyBiosig Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap284.14MEPS (ttm)-0.62
P/E-EPS this Y66.67%
Forward P/E-EPS next Y32.00%
PEG-EPS past 5Y46.11%
P/S9471.33EPS next 5Y-
P/B96.90EPS Q/Q62.27%
Dividend-Sales Q/Q-100.00%
Insider Own39.71%Inst Own27.68%
Insider Trans0.00%Inst Trans8.13%
Short Float7.90%EarningsMay 19
Analyst Recom1.00Target Price10.00
Avg Volume775.77K52W Range0.23 - 9.83
Jun-09-25 10:30AM BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors (GlobeNewswire) -14.05%
Jun-04-25 08:25AM BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor (GlobeNewswire) -10.59%
May-28-25 06:45PM CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO) (GlobeNewswire) -8.74% -13.68%
01:46PM BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (GlobeNewswire)
01:07PM Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq (GlobeNewswire)
May-27-25 08:20AM BioSig Technologies signs definitive share exchange agreement with Streamex (TipRanks) +21.40%
May-26-25 12:42PM BioSig Stock Surges Following Share Exchange Deal With Streamex (Zacks)
May-25-25 06:31PM BioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex Acquisition (Insider Monkey)
May-23-25 07:56PM BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain. (GlobeNewswire) +24.24% +21.40%
May-05-25 09:42AM BioSig Enters into an LOI to Merge with Streamex Exchange Corp. (GlobeNewswire) +5.84%
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Los Angeles, CA.
LHSW - Lianhe Sowell International Group Ltd - Stock Price Chart
TickerLHSW [NASD]
CompanyLianhe Sowell International Group Ltd
CountryChina
IndustrySoftware - Infrastructure
Market Cap114.92MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B11.26EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own65.80%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.76%Earnings-
Analyst Recom-Target Price-
Avg Volume634.12K52W Range0.99 - 8.18
Lianhe Sowell International Group Ltd. is a holding company, which engages in trading of electronic products and software development. Its products include Intelligent traffic, low voltage Intelligent Integration, Industrial Intelligence, Industrial machine vision, and precision visual Al painting robot. The company was founded by Yue Zhu on April 6, 2007 and is headquartered in Shenzhen, China.
U - Unity Software Inc - Stock Price Chart
TickerU [NYSE]
CompanyUnity Software Inc
CountryUSA
IndustrySoftware - Application
Market Cap10.86BEPS (ttm)-1.12
P/E-EPS this Y-30.63%
Forward P/E32.55EPS next Y8.77%
PEG-EPS past 5Y-22.36%
P/S6.08EPS next 5Y-2.31%
P/B3.41EPS Q/Q74.93%
Dividend-Sales Q/Q-5.51%
Insider Own23.59%Inst Own62.82%
Insider Trans-2.20%Inst Trans14.22%
Short Float9.28%EarningsMay 07/b
Analyst Recom2.06Target Price25.50
Avg Volume11.52M52W Range13.90 - 30.88
Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tomer Bar-ZeevDirectorJul 01 '25Proposed Sale24.01150,0003,601,500Jul 01 04:53 PM
Kostman DavidFormer DirectorJun 30 '25Proposed Sale23.8924,014573,663Jun 30 04:11 PM
Barrysmith MarkOfficerJun 16 '25Proposed Sale24.091,26830,551Jun 16 04:29 PM
Dovrat ShlomoDirectorJun 12 '25Sale25.0115,782394,708239,089Jun 16 03:12 PM
Barrysmith MarkChief Accounting OfficerJun 16 '25Sale24.091,26830,546465,383Jun 16 03:05 PM
CYBN - Cybin Inc - Stock Price Chart
TickerCYBN [AMEX]
CompanyCybin Inc
CountryCanada
IndustryBiotechnology
Market Cap182.86MEPS (ttm)-4.05
P/E-EPS this Y17.11%
Forward P/E-EPS next Y17.33%
PEG-EPS past 5Y-232.48%
P/S-EPS next 5Y45.75%
P/B1.04EPS Q/Q-28.89%
Dividend-Sales Q/Q-
Insider Own11.46%Inst Own32.58%
Insider Trans0.00%Inst Trans36.06%
Short Float5.13%EarningsJul 01/b
Analyst Recom1.00Target Price91.66
Avg Volume333.81K52W Range4.81 - 13.88
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.
SWIN - Solowin Holdings - Stock Price Chart
TickerSWIN [NASD]
CompanySolowin Holdings
CountryHong Kong
IndustryCapital Markets
Market Cap219.21MEPS (ttm)-0.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-118.12%
P/S608.92EPS next 5Y-
P/B104.07EPS Q/Q33.83%
Dividend-Sales Q/Q7.39%
Insider Own73.23%Inst Own0.08%
Insider Trans0.00%Inst Trans-45.74%
Short Float0.25%Earnings-
Analyst Recom-Target Price-
Avg Volume182.26K52W Range1.16 - 3.69
Solowin Holdings engages in the provision of securities brokerage solutions through its subsidiary. It operates through the following segments: Securities Related Services, Investment Advisory Services, Asset Management Services, and Corporate Consultancy Services. The Securities Related Services segment is involved in offering securities dealing and brokerage services, securities underwriting and placing services, and other financing services. The Investment Advisory Services segment offers investment solutions advisory services for clients, through a team consisting of financial analysts, financial advisors, and investment managers. The Asset Management Services segment specializes in designing investment portfolios for investors with different risk appetites and to preserve the value of assets. The Corporate Consultancy Services pertains to the financial and independent financial advisory services for unlisted and listed companies that are looking for high-quality and value-added corporate finance advisory services at reasonable costs. The company was founded on July 23, 2021, and is headquartered in Hong Kong.
CGC - Canopy Growth Corporation - Stock Price Chart
TickerCGC [NASD]
CompanyCanopy Growth Corporation
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap232.20MEPS (ttm)-4.04
P/E-EPS this Y89.52%
Forward P/E-EPS next Y-0.29%
PEG-EPS past 5Y32.50%
P/S1.20EPS next 5Y63.95%
P/B0.70EPS Q/Q-30.14%
Dividend-Sales Q/Q-16.03%
Insider Own1.69%Inst Own8.40%
Insider Trans-2.91%Inst Trans57.58%
Short Float9.85%EarningsMay 30/b
Analyst Recom3.33Target Price2.24
Avg Volume7.96M52W Range0.77 - 8.65
Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, International Markets Cannabis, Storz and Bickel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The International Markets Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yanofsky TheresaDirectorJun 30 '25Sale1.2310,42512,82384,360Jul 02 04:16 PM
Kruh WillyDirectorJun 30 '25Sale1.2310,46812,87673,390Jul 02 04:16 PM
Lazzarato David AngeloDirectorJun 30 '25Sale1.2315,70119,312119,064Jul 02 04:15 PM
Hong Judy Eun JooChief Financial OfficerJun 16 '25Sale1.6338,67862,866579,889Jun 17 04:05 PM
Gedeon ChristelleSee RemarksJun 16 '25Sale1.479,55514,046389,945Jun 17 04:05 PM
AAPG - Ascentage Pharma Group International ADR - Stock Price Chart
TickerAAPG [NASD]
CompanyAscentage Pharma Group International ADR
CountryChina
IndustryBiotechnology
Market Cap3.72BEPS (ttm)-0.75
P/E-EPS this Y-104.53%
Forward P/E49.11EPS next Y157.81%
PEG-EPS past 5Y36.70%
P/S27.33EPS next 5Y41.39%
P/B92.86EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.27%
Insider Trans-Inst Trans44.23%
Short Float-EarningsMar 27/b
Analyst Recom1.00Target Price27.00
Avg Volume25.93K52W Range16.50 - 40.81
Jun-15-25 07:30PM EHA 2025 Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL (GlobeNewswire)
Jun-09-25 07:30PM Thirteen Studies of Ascentage Pharma's Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress (GlobeNewswire) +5.29%
Jun-02-25 07:30PM Live from ASCO 2025 Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors (GlobeNewswire) +10.03%
07:30PM Live from ASCO 2025 Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report (GlobeNewswire)
May-22-25 08:15PM Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025 (GlobeNewswire)
May-11-25 05:20PM Is Ascentage Pharma (AAPG) the Best Performing Healthcare Stock to Buy Now? (Insider Monkey)
Apr-28-25 07:00AM Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax (GlobeNewswire)
Apr-23-25 07:00PM Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin (GlobeNewswire) +10.65% +6.69%
Apr-21-25 06:10PM Ascentage Pharma Drugs Included in Chinese Society of Clinical Oncology Guidelines (Exec Edge) +12.97%
07:00AM Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology (CSCO) 2025 Guidelines (GlobeNewswire)
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
UMAC - Unusual Machines Inc - Stock Price Chart
TickerUMAC [AMEX]
CompanyUnusual Machines Inc
CountryUSA
IndustryComputer Hardware
Market Cap216.77MEPS (ttm)-3.76
P/E-EPS this Y90.10%
Forward P/E-EPS next Y43.42%
PEG-EPS past 5Y-
P/S31.01EPS next 5Y-
P/B9.24EPS Q/Q-12.67%
Dividend-Sales Q/Q229.98%
Insider Own19.77%Inst Own4.66%
Insider Trans-2.85%Inst Trans60.88%
Short Float14.97%EarningsMay 08/b
Analyst Recom1.00Target Price18.00
Avg Volume2.92M52W Range1.13 - 23.62
Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Camden Andrew RossChief Operating OfficerJun 16 '25Sale10.0025,000250,000158,500Jun 17 04:02 PM
Camden Andrew RossOfficerJun 16 '25Proposed Sale10.0025,000250,000Jun 16 04:02 PM
Camden Andrew RossChief Operating OfficerMay 20 '25Sale5.4217,50094,888183,500May 20 04:03 PM
Hoff Brian JosephChief Financial OfficerMay 20 '25Sale5.4117,50094,591341,725May 20 04:03 PM
Hoff Brian JosephOfficerMay 20 '25Proposed Sale5.4417,50095,200May 20 08:59 AM
18910111213141516171820